A 5 mg vial of lyophilized BPC-157 from a research-supply vendor runs roughly $28 to $65 in single quantities as of mid-2026; a 10 mg vial runs $45 to $110. Normalized, that is about $4.50 to $11.00 per milligram. Case pricing at 10 vials or more typically lands between $3.20 and $6.00 per mg. Catalog chemical houses selling the same sequence under a full analytical dossier — Bachem, MedChemExpress, Tocris-tier suppliers — charge $180 to $600 for 5 mg, or $36 to $120 per mg: a 5x to 20x premium. That spread is not arbitrary. It maps to documentation depth, net peptide content, and which party absorbs the cost of a failed lot.
Why the same sequence spans a 20x price range
BPC-157 is a 15-residue partial sequence (GEPPPGKPADDAGLV) with an average molecular weight of 1419.5 Da. It is a short, unmodified, linear peptide with no disulfide bridges, no cyclization, and no unusual residues — which makes it cheap to produce by standard Fmoc solid-phase synthesis. Raw synthesis cost at contract scale, for a 100 g order, has been quoted in the $0.40 to $1.50 per mg range. Nothing about the molecule justifies $120/mg on chemistry alone.
What separates the tiers is everything wrapped around the powder:
- Analytical depth. A single RP-HPLC purity trace is cheap. A dossier with HPLC purity, ESI-MS or MALDI-TOF identity confirmation, amino acid analysis, Karl Fischer water content, residual solvent screen, and counterion quantification costs the supplier $400 to $1,200 per lot to produce.
- Lot size economics. A supplier amortizing a $900 analytical package across a 5 g lot adds $0.18/mg. Amortized across a 250 mg lot, the same package adds $3.60/mg.
- Batch traceability infrastructure. Lot-level records, retained samples, and a queryable CoA archive are a real operating expense, not a marketing line.
- Risk transfer. Catalog houses will replace or credit an out-of-spec lot without argument. Low-tier vendors frequently will not, and their returns terms are where that shows up.
- Salt form. Most BPC-157 ships as the TFA salt. Exchange to acetate adds $80 to $200 per lot in processing and typically 1 to 2 weeks of lead time.
Net peptide content is the number that actually sets your cost per mg
This is the single most under-discussed variable in BPC-157 pricing, and it is where nominal price comparisons fall apart.
A vial labeled "10 mg" is usually 10 mg of gross lyophilized solid, not 10 mg of peptide. That solid contains three things: the peptide, the counterion, and residual water.
- TFA counterion on a peptide with two basic sites commonly accounts for 5% to 15% of the gross mass.
- Residual moisture, by Karl Fischer titration, typically runs 3% to 8% in a properly lyophilized cake, and higher in a poorly sealed or humidity-exposed one.
- Net peptide content therefore lands somewhere around 78% to 88% for a normal TFA-salt preparation.
A vendor selling a nominal 10 mg vial at $60 with 80% net content is charging $7.50 per mg of actual peptide, not $6.00. A vendor at $75 with a documented 91% net content is charging $8.24/mg — an 10% difference from the headline, in the opposite direction from what the sticker suggests.
Almost no research-supply vendor publishes net peptide content. If a supplier's CoA reports only "Purity: 99.1% by HPLC" and nothing else, that figure describes the relative area of the main chromatographic peak against other UV-absorbing species. It says nothing about how much of the vial is water and salt. Two vials can both be "99% pure" and differ by 15% in delivered peptide mass.
Chromatographic purity and net peptide content are different measurements answering different questions. A CoA that reports only the first is describing the peptide it contains, not the amount of it you bought.
What independent verification costs if you pay for it yourself
Any lab that treats the supplier CoA as an unverified claim should budget for confirmation. Current US third-party analytical pricing:
- RP-HPLC purity, single sample injection with a standard gradient: $150 to $400, 3 to 7 business days.
- LC-MS identity confirmation: $200 to $500. For BPC-157 the expected observations are the [M+H]⁺ at m/z ~1420.5 and commonly the [M+2H]²⁺ at ~710.8.
- Combined purity + identity panel: $300 to $650 when ordered together.
- Amino acid analysis for true net peptide content: $250 to $450.
- Endotoxin (LAL) and sterility, where the analytical protocol requires them: $200 to $600 combined.
Verifying one lot end-to-end therefore costs $750 to $1,500. On a single $60 vial that is economically absurd. On a 50-vial purchase representing $2,400 of material and several months of downstream work, it is roughly 30% of material cost and often the cheapest insurance in the project. The break-even point sits near $700 to $900 of material — below that, buying from a supplier whose documentation you already trust beats paying to re-derive it.
We publish our own analytical position on the quality page, and a supplier-by-supplier comparison in the library.
Cold chain, shipping, and the carrying cost of storage
Lyophilized BPC-157 is stable enough that shipping cost is modest, which surprises buyers who expect pharmaceutical-grade logistics pricing.
- Ambient or gel-pack ground shipping: $8 to $25 domestically, and most vendors go free above a $150 to $300 order threshold. See shipping for specifics.
- Overnight with 2–8°C ice packs: $35 to $95, rarely necessary for the lyophilized form, which tolerates several days at ambient without measurable degradation.
- Long-term storage at -20°C: manufacturer-stated shelf life is commonly 24 to 36 months. At 2–8°C it drops to roughly 6 to 12 months for the sealed lyophilized cake.
- Freezer capacity cost: a -20°C lab freezer runs $1,200 to $4,000 up front plus $90 to $250 per year in electricity. Spread across a few hundred vials this is negligible; for a lab buying six vials a year it is the dominant cost line.
When buying BPC-157 is not worth the money
Plainly, and against our own interest:
- You have no analytical capability and no budget to outsource it. If nothing in the workflow can distinguish a 99% lot from an 82% lot, you are paying a documentation premium for a document you cannot check. A $28 vial and a $600 vial will produce identical results in your hands: uninterpretable ones. Fix the analytical gap first.
- Your protocol requires GMP material. Research-use-only reference material is not GMP, is not sterile-filled unless explicitly stated, and carries no pharmacopeial release. No amount of purity documentation converts it. If a regulatory pathway, IRB, or downstream filing requires GMP, buy GMP and expect $3,000 to $15,000 per gram. Anything cheaper is the wrong product, not a bargain. Our research use only terms state this directly.
- You need lot-to-lot consistency across a multi-year study. Most research-supply vendors do not reserve inventory. Lot 240118 and lot 251203 may come from different contract manufacturers with different impurity profiles. If your study design cannot survive that, buy one large lot up front from a supplier that will retain samples, and accept the higher unit price and the freezer commitment.
- You are buying under 5 mg total. Per-mg pricing at that scale is punishing — often $12 to $20 per mg once shipping is loaded in — and the analytical overhead cannot be amortized. Buying 25 mg is frequently cheaper in absolute dollars than three separate 5 mg orders across a year, once you count $15 to $25 of shipping per order.
- Price is your primary selection criterion. The floor of this market — vials at $14 to $22 — exists because someone removed a cost. Usually it is the analytical package, sometimes it is the lot size the CoA actually describes. A CoA that carries no lot number, no analysis date, and no analyst signature is a template, not a test result. Roughly a third of low-tier listings we have reviewed reuse a single chromatogram across unrelated lots.
Failure modes that turn a cheap vial into an expensive month
- CoA/lot mismatch. The certificate references a lot number not printed on the vial. Nothing on that document describes the material in your hand.
- Undated or undisclosed synthesis date. A vial synthesized 30 months ago and stored at ambient has consumed most of its stated shelf life before it reached you. Ask for the synthesis date, not just the expiry.
- Deamidation at the Asp-Asp-Ala segment. BPC-157 contains an aspartate pair, and aspartate-adjacent sequences are a known site for deamidation and isomerization under humidity and thermal stress. These degradants can co-elute closely with the parent peak on a short gradient, so a fast QC method can report high purity on material that a longer method would flag. A CoA that discloses gradient, column, and run time is materially more informative than one reporting a bare percentage.
- Vial-to-vial fill variance. Fill tolerance of ±5% is normal on automated lines; hand-filled operations run ±10% to ±15%. Across a 20-vial case that variance is larger than the price difference between most suppliers.
The cost worksheet worth running before ordering
Compute a true landed cost per milligram of peptide, not per vial:
(vial price + prorated shipping) ÷ (nominal mg × net peptide fraction × HPLC purity)
A $55 nominal-10 mg vial, $3 prorated shipping, 82% net content, 98.5% purity = $7.18 per mg delivered. A $78 vial with 90% net content and 99.2% purity = $8.74 per mg — 22% more, for material whose composition is actually documented. Whether that 22% is worth paying depends entirely on what a failed lot costs your project, which is a number you know and we do not.
Volume changes the arithmetic sharply. Order tiers usually break at 10, 25, and 100 vials, with discounts of roughly 8%, 15%, and 25%. Genuine wholesale terms typically start near a $1,000 to $2,500 minimum and can reach $2.80/mg. If a supplier offers wholesale pricing at a $200 minimum, that is retail with a different label. Comparative supplier notes are collected in best bpc 157 made in usa.
All materials described here are reference chemicals for laboratory research use only, not for human or veterinary use. See our disclaimer for full terms.
Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.